文献速递肺外科

微创肺叶切除术的肿瘤学等效性:科学与实践论据

Oncologic Equivalence of Minimally Invasive Lobectomy: The Scientific and Practical Arguments.
PubMed 文献 · Ann Thorac Surg · 2018-04-17

该综述基于在线数据库回顾分析、文献汇编及作者经验,汇总开放与微创肺叶切除术(MIL)长期生存比较报告,认为多数随机及倾向匹配分析显示早期肺癌MIL长期生存等效或更优,MIL应作为肺叶切除术的首选技术。

要点

  • 多数有限随机试验及大量倾向匹配数据库分析显示,早期肺癌MIL长期生存等效或更优。
  • MIL淋巴结清扫质量曾受质疑,早期报告归因于MIL避免中心型肿瘤。
  • 对高龄、衰弱等特殊人群,证据更强显示MIL带来生存优势。

核心结论

  • MIL是肿瘤学等效的手术,且发病率显著更低,尤其在衰弱人群中。
  • 作者认为MIL应成为肺叶切除术的首选技术,甚至可作为质量指标。

研究设计与样本

  • 回顾性分析在线数据库、收集的文献阅读及经验丰富作者的其他学术经验构建本综述。
  • 汇总所有包含开放与MIL长期生存比较的报告。

主要发现

  • 多数有限随机试验及大量大型倾向匹配数据库分析表明,早期疾病MIL长期生存等效或更优。
  • MIL淋巴结清扫质量曾受质疑,但早期报告将其归因于MIL避免中心型肿瘤。
  • 尽管晚期癌症切除中MIL技术不足应被放大,早期报告显示无此类担忧。
  • 对高龄、衰弱等特殊人群,证据更强显示MIL带来生存优势。

关键数值与推荐

  • 早期疾病MIL长期生存等效或更优(基于多数有限随机试验及大量倾向匹配数据库分析)。
  • 高龄、衰弱患者中MIL生存优势证据更强。

临床怎么用

  • 作者认为MIL应成为肺叶切除术的首选技术,甚至可作为质量指标。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite the slow adoption of minimally invasive lobectomy (MIL), it is now a preferred approach for early lung cancer. Nevertheless, ongoing concerns about MIL oncologic effectiveness has led to calls for prospective, randomized trials. METHODS: Retrospective analysis of on-line databases, collected readings, and other scholarly experiences of the experienced authors were used to construct this review. All available reports that contained long-term survival comparisons for open versus MIL were tabulated. RESULTS: The preponderance of limited randomized and numerous large propensity-matched database analyses indicate equivalent or improved long-term MIL survival for early-stage disease. MIL lymph node dissection quality has been challenged; however, this was attributed to MIL avoidance of central tumors in early reports. Although technical inadequacies for MIL should be amplified for advanced cancer resections, early reports show no such concern. In fact, for special populations such as older, frail patients, evidence is much stronger that MIL confers a survival advantage. CONCLUSIONS: MIL is an oncologically equivalent operation with substantially less morbidity, especially in frail populations. It is reasonable to suggest that MIL should be the technique of choice, even a quality indicator, for lobectomy.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Demmy TL, Yendamuri S, D'Amico TA, et al. Oncologic Equivalence of Minimally Invasive Lobectomy: The Scientific and Practical Arguments. Ann Thorac Surg. 2018. PMID: 29678519. doi:10.1016/j.athoracsur.2018.02.089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。